Revenue increased 9.1% year over year to $2.9 billion while expenses increased 6.5% to $3 billion, according to financial documents published Feb. 21. Labor costs grew by 7.4% year over year to $1.86 billion while supply costs increased 6.2% to $903.9 million.
After accounting for nonoperating items, such as investments returns, Nuvance reported a $7 million net loss in fiscal 2024, compared to a $121.4 million net loss in fiscal 2023.
As of Sept. 30, 2024, long term-debt was $944.8 million.
Nuvance’s improved financial results come ahead of its planned merger with New Hyde Park, N.Y.-based Northwell Health. The proposed merger would create a nonprofit, regional health system with 28 hospitals across Connecticut and New York, 14,500 providers and more than 1,000 care sites.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
